Extension of Exclusive Agreement with Nouryon

Summary by AI ^BETAClose X

Quadrise PLC has extended its Exclusive Global Collaboration and Emulsifiers Sales Agreement with Nouryon, a specialty chemicals leader, through October 31, 2026, to ensure the exclusive supply of goods, services, and intellectual property for future MSAR® and bioMSAR™ projects. This renewed partnership, originally announced on October 8, 2019, continues the commercial relationship where Quadrise purchases specialized emulsifier chemicals exclusively from Nouryon for its oil-in-water emulsion fuel and biofuel applications. Intellectual property arising from joint development or past work on MSAR® and bioMSAR™ will remain jointly owned, and the agreement maintains exclusivity in the field of oil-in-water emulsion fuels and biofuels research and development.

Disclaimer*

Quadrise PLC

12 January 2026

Quadrise plc

("Quadrise", "QED" or the "Company")

Extension of Exclusive Agreement with Nouryon

Quadrise plc (AIM: QED), the technology company focused on the decarbonisation of shipping and heavy industry through deployment of low emission fuels and biofuels, is pleased to announce the extension of the Exclusive Global Collaboration and Emulsifiers Sales Agreement ("Agreement") with Nouryon, a global specialty chemicals leader, for the exclusive supply of goods, services and IP for future MSAR® and bioMSAR™ projects.

The Agreement, the terms of which were announced on 8 October 2019, was renewed on 9 January 2026 to cover the period up to and including 31 October 2026.

Commenting on the Agreement, Jason Miles, CTO of Quadrise, said:

"We are pleased to renew our exclusive partnership with Nouryon, which continues to underpin the development and commercialisation of our MSAR® and bioMSAR™ fuels. This agreement reflects our shared commitment to delivering innovative, sustainable solutions for the marine, energy and industrial sectors."

Background to the Nouryon Agreement:

The Agreement between Quadrise International Limited ("QIL"), a subsidiary of the Company, and Nouryon Surface Chemistry AB ("NSC") continues the commercial relationship between the parties relating to the purchase and supply of goods and associated technical services to MSAR® and bioMSAR™ projects in development. QIL purchases, and will continue to purchase, speciality chemicals used as emulsifiers exclusively from NSC, which NSC supplies exclusively to QIL for oil-in-water emulsion fuel and biofuel applications.

Intellectual Property arising from any future joint development activity, or relating to past work such as MSAR® and bioMSAR™ development, is jointly owned between the parties in agreed territories. The Agreement is exclusive in the field of oil-in-water emulsion fuels and biofuels research and development unless otherwise agreed jointly.

For further information please contact:

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Peter Borup, Chief Executive Officer

Nominated Adviser

Cavendish Capital Markets Limited

+44 (0)20 7220 0500

Ben Jeynes

George Lawson

Joint Brokers

Shore Capital Stockbrokers Limited

+44 (0)20 7408 4090

Toby Gibbs / Harry Davies-Ball (Corporate Advisory)

Fiona Conroy (Corporate Broking)

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

+44 (0)20 3005 5000

Public & Investor Relations

Tavistock Communications (Financial PR & IR)

Simon Hudson

Nick Elwes

Saskia Sizen

+44 (0) 20 7920 3150

BLUE Communications Limited (Marine & Trade PR)

Rhys Thomas

Sam Deacon

+44 (0)7595 227750

+44 (0)7527 558846

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to lower energy costs, pollution and greenhouse gas emissions today for the global power generation, shipping, industrial and oil industries.

Learn more at: www.quadrise.com

LinkedIn: @Quadrise Plc

X: @QuadrisePlc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END